Cargando…
An autophagosome-based therapeutic vaccine for HBV infection: a preclinical evaluation
BACKGROUND: For more than 240 million chronic HBV carriers worldwide, effective therapeutic HBV vaccines are urgently needed. Recently, we demonstrated that autophagosomes were efficient antigens carriers and capable to cross-prime robust T-cell responses and mediate regression of multiple establish...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301925/ https://www.ncbi.nlm.nih.gov/pubmed/25526800 http://dx.doi.org/10.1186/s12967-014-0361-4 |